Chronic obstructive pulmonary disease, commonly called COPD, is one of the leading causes of illness and death worldwide. The ...
), an innovator and pioneer in developing products for the treatment of sleep-disordered breathing and respiratory conditions. The Food and Drug Administration (FDA) recently cleared ResMed's home ...
The American Thoracic Society (ATS) and Sunovion Pharmaceuticals Inc. (Sunovion) today announced the results of a survey of pulmonologists and pulmonology fellows to determine physicians’ knowledge, ...
Please provide your email address to receive an email when new articles are posted on . Available studies on wearable devices and COPD exacerbations have differing data collection methods. Patient ...
Credit: Getty Images. The 2024 GOLD COPD Report includes updated research and recommendations that reflect shifts in thinking on COPD management. Vogelmeier, who heads the Department of Medicine, ...
Chronic obstructive pulmonary disease, or COPD, is one of the world’s leading causes of death, responsible for 3.5 million deaths in 2021 alone. It is often thought of as a disease of older smokers.
Many people with chronic obstructive pulmonary disease (COPD) experience severe fatigue that can limit their ability to perform daily activities. A 2021 review found fatigue was a symptom of COPD in ...
Cardiovascular diseases and diabetes are some of the most common coexisting conditions in COPD. Shared risk factors and overlapping physiological processes likely contribute to the high rate of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results